Showing results (781-790 of 3,103) with videos related to
Sort By:
Pageof 311
Drug Safety|July 13, 2002
Safety of unoprostone isopropyl as mono- or adjunctive therapy in patients with primary open-angle glaucoma or ocular hypertensionPaulo Augusto de Arruda Mello, Natalia C Yannoulis, Reza M HaqueDrug Safety|May 8, 2002
Is aspirin a cause of Reye's syndrome? A case againstJames P Orlowski, Usama A Hanhan, Mariano R FiallosDrug Safety|May 8, 2002
Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety reviewBruce I Gaynes, Richard FiscellaDrug Safety|May 8, 2002
Determinants of headache in lansoprazole users in The Netherlands: results from a nested case-control studyAngela A M C Claessens, Eibert R Heerdink, Jacques T H M van Eijk, et al.Drug Safety|September 12, 2002
Myocardial infarction in the elderly: benefits and risks of thrombolyticsWilbert S AronowDrug Safety|September 12, 2002
Comparison of losartan with ACE inhibitors and dihydropyridine calcium channel antagonists: a pilot study of prescription-event monitoring in JapanKazuo Samizo, Eri Kawabe, Shiro Hinotsu, et al.Drug Safety|September 12, 2002
Incidence of herb-induced aconitine poisoning in Hong Kong: impact of publicity measures to promote awareness among the herbalists and the publicThomas Y K ChanDrug Safety|September 21, 2002
A benefit-risk assessment of extended-release oxybutyninMartin C MichelDrug Safety|September 21, 2002
Oxidation injury in patients receiving HMG-CoA reductase inhibitors: occurrence in patients without enzyme elevation or myopathyHelmut Sinzinger, Fahdi Chehne, Graziana LupattelliDrug Safety|June 23, 2001
Evaluation of drug-induced QT interval prolongation: implications for drug approval and labellingM Malik, A J CammPageof 311